Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 1
2008 1
2009 4
2010 4
2011 2
2012 2
2013 4
2014 3
2015 1
2017 3
2018 3
2019 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean paolorigano (2 results)?
Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.
Pinto VM, Gianesin B, Piel FB, Longo F, Rigano P, Quota A, Spadola V, Graziadei G, Mazzi F, Cappellini MD, Maggio A, Piga A, De Franceschi L, Forni GL. Pinto VM, et al. Among authors: rigano p. Haematologica. 2023 Apr 1;108(4):1158-1162. doi: 10.3324/haematol.2022.280815. Haematologica. 2023. PMID: 35924578 Free PMC article. No abstract available.
The use of hydroxyurea in the real life of MIOT network: an observational study.
Ricchi P, Meloni A, Rigano P, Pistoia L, Spasiano A, Allò M, Messina G, Quarta A, Rosso R, Quota A, Filosa A, Maggio A, Pepe A. Ricchi P, et al. Among authors: rigano p. Expert Opin Drug Saf. 2022 Nov;21(11):1433-1440. doi: 10.1080/14740338.2022.2064980. Epub 2022 Apr 17. Expert Opin Drug Saf. 2022. PMID: 35435090
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.
Graziadei G, De Franceschi L, Sainati L, Venturelli D, Masera N, Bonomo P, Vassanelli A, Casale M, Lodi G, Voi V, Rigano P, Pinto VM, Quota A, Notarangelo LD, Russo G, Allò M, Rosso R, D'Ascola D, Facchini E, Macchi S, Arcioni F, Bonetti F, Rossi E, Sau A, Campisi S, Colarusso G, Giona F, Lisi R, Giordano P, Boscarol G, Filosa A, Marktel S, Maroni P, Murgia M, Origa R, Longo F, Bortolotti M, Colombatti R, Di Maggio R, Mariani R, Piperno A, Corti P, Fidone C, Palazzi G, Badalamenti L, Gianesin B, Piel FB, Forni GL. Graziadei G, et al. Among authors: rigano p. Front Med (Lausanne). 2022 Mar 16;9:832154. doi: 10.3389/fmed.2022.832154. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35372393 Free PMC article.
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm.
Baronciani D, Casale M, De Franceschi L, Graziadei G, Longo F, Origa R, Rigano P, Pinto V, Marchetti M, Gigante A, Forni GL. Baronciani D, et al. Among authors: rigano p. Hemasphere. 2021 Apr 29;5(5):e555. doi: 10.1097/HS9.0000000000000555. eCollection 2021 May. Hemasphere. 2021. PMID: 33969274 Free PMC article. Review.
Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.
Vitrano A, Ruffo GB, Pepe A, D'Ascola DG, Caruso V, Filosa A, Masera N, Pitrolo L, Rigano P, Cuccia L, Giangreco A, Di Maggio R, Maggio A. Vitrano A, et al. Among authors: rigano p. Br J Haematol. 2019 Sep;186(6):e209-e211. doi: 10.1111/bjh.16101. Epub 2019 Jul 25. Br J Haematol. 2019. PMID: 31344255 Free article. Clinical Trial. No abstract available.
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL. Russo G, et al. Among authors: rigano p. Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0. Orphanet J Rare Dis. 2019. PMID: 31146777 Free PMC article. Review.
Access to emergency departments for acute events and identification of sickle cell disease in refugees.
De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL. De Franceschi L, et al. Among authors: rigano p. Blood. 2019 May 9;133(19):2100-2103. doi: 10.1182/blood-2018-09-876508. Epub 2019 Feb 11. Blood. 2019. PMID: 30745303 Free article. No abstract available.
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
Rigano P, De Franceschi L, Sainati L, Piga A, Piel FB, Cappellini MD, Fidone C, Masera N, Palazzi G, Gianesin B, Forni GL; Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators. Rigano P, et al. Blood Cells Mol Dis. 2018 Mar;69:82-89. doi: 10.1016/j.bcmd.2017.08.017. Epub 2017 Oct 9. Blood Cells Mol Dis. 2018. PMID: 29107441 Free article.
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.
Origa R, Ponti ML, Filosa A, Galeota Lanza A, Piga A, Saracco GM, Pinto V, Picciotto A, Rigano P, Madonia S, Rosso R, D'Ascola D, Cappellini MD, D'Ambrosio R, Tartaglione I, De Franceschi L, Gianesin B, Di Marco V, Forni GL; Italy for THAlassemia and hepatitis C Advance - Società Italiana Talassemie ed Emoglobinopatie (ITHACA-SITE). Origa R, et al. Among authors: rigano p. Am J Hematol. 2017 Dec;92(12):1349-1355. doi: 10.1002/ajh.24911. Epub 2017 Oct 19. Am J Hematol. 2017. PMID: 28929515 Free article.
36 results